Effectiveness of subcutaneous low-dose alemtuzumab and rituximab combination therapy for steroid-resistant chronic graft-versus-host disease

BACKGROUND: Chronic graft-versus-host disease is a common late complication of allogeneic hematopoietic stem cell transplantation. Corticosteroids are the standard initial treatment. Second-line treatment has not been well defined. We evaluated the effectiveness and safety of low doses of alemtuzuma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gutiérrez-Aguirre, Cesar Homero, Cantú-Rodríguez, Olga Graciela, Borjas-Almaguer, Omar David, González-Llano, Oscar, Jaime-Pérez, José Carlos, Solano-Genesta, Manuel, Gómez-Guijosa, Miguel, Mancias-Guerra, Consuelo, Tarin, Luz, Gómez-Almaguer, David
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2012
Assuntos:
Original Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3342974/
https://ncbi.nlm.nih.gov/pubmed/22133770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.054577
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados